Cancer Research
- Agendia BV Announces That Its Chief Research Officer Laura Van't Veer Has Received A 2007 Breast Cancer Research Foundation Awar
-
CupPrint(R) is based on a license to the TUA database of AviaraDx Contact Information: Agendia: Laura van ...
Article - Anna Ohlden - Oct 22 2007 - 10:13am
- Agendia BV Appoints Clinical And Scientific Advisory Board
-
oncology. (i) CupPrint(R) is based on a license to the TUO database of AviaraDx Contact Information: ...
Article - Anna Ohlden - Oct 29 2007 - 12:11pm
- 90% Gone In Some Areas: How To Save Tasmanian Devils?
-
devil to another when tumor cells are transplanted through fighting, biting, and other physical contact ...
Article - News Staff - Jan 28 2008 - 5:33pm
- Cancer Pioneer Reaches Key Agreement On Colon Cancer Drug OncoVAX(R)
-
www.vaccinogeninc.com Contact: Andrew L. Tussing Vaccinogen atussing@vaccinogeninc.com +1-301-668-8400 Web site: ...
Article - Anna Ohlden - Feb 11 2008 - 3:31pm
- Unite Accuses Semiconductor Companies Of Living In An Alice In Wonderland Fantasy Over Workers' Safety
-
contact Peter Skyte on: +44(0)7768-93-13-02 or Ashraf Choudhury in the Unite Press Office on ...
Article - Anna Ohlden - Apr 28 2008 - 4:31am
- Copycat Cell- Polymers Mimic Surface Of The Real Thing
-
synthetic capsule to the bacteria when they are in physical contact, which is an exciting development. ...
Article - News Staff - May 28 2008 - 11:24am
- Kiadis Pharma Announces Collaboration With The Julius Maximilians University Of Würzburg, Germany
-
May 29 /PRNewswire/-- For more information please contact: Kiadis Pharma B.V., Eefje Simpelaar, ...
Article - Anna Ohlden - May 29 2008 - 5:30am
- Axelar Receives Financing For A Phase I/II Clinical Trial On Cancer Patients With The New Anti-Cancer Drug AXL1717
-
more information, please contact: Johan Harmenberg, MD, PhD (CEO Axelar AB), Telephone: ...
Article - Anna Ohlden - Jun 12 2008 - 6:32am
- Axelar Initiates Phase I/II Clinical Trial On Cancer Patients With The New Anti-Cancer Drug AXl1717
-
angioplasty, and macula degeneration. Visit http://www.axelar.se. For more information, please contact: Johan ...
Article - Anna Ohlden - Jun 17 2008 - 6:33am
- Bavarian Nordic Reports Interim Data From Phase I/II Studies With Breast Cancer Vaccine
-
Contact: Anders Hedegaard, President & CEO, +45-23-20-30-64 ...
Article - Anna Ohlden - Jun 19 2008 - 2:33am
Know Science And Want To Write?
Donate or Buy SWAG
Please donate so science experts can write
for the public.
At Science 2.0, scientists are the journalists,
with no political bias or editorial control. We
can't do it alone so please make a difference.
We are a nonprofit science journalism
group operating under Section 501(c)(3)
of the Internal Revenue Code that's
educated over 300 million people.
You can help with a tax-deductible
donation today and 100 percent of your
gift will go toward our programs,
no salaries or offices.
